MAR 20, 2018 9:17 PM PDT

Treatment for Post-Surgical Nausea and Vomiting

WRITTEN BY: Nouran Amin

Amisulpride, a drug developed for the treatment of schizophrenia, was studied to be effective in preventing postoperative nausea and vomiting (PONV). The drug was seen to decrease the development of PONV when used in combination with a standard anti-nausea treatment; administered intraoperatively.

"Tens of millions of Americans undergo surgery each year, and many suffer from nausea and vomiting after their operation," says Dr. Kranke, a professor of anesthesiology at the University of Würzburg in Germany."Post-operative nausea and vomiting contribute to patient distress, can delay recovery after surgery and increases hospital costs. Patients with multiple risk factors for PONV require a multimodal approach for its prevention, including using a combination of anti-nausea drugs with different mechanisms of action, since it cannot be predicted which pathway(s) will be active in a patient."

A significant factor associated with the development of PONV has a lot to do with gender; female surgical patients are more likely to be at risk. Other risk factors include a prior history of PONV, being prone to motion sickness, nonsmoking individuals, and those in need of opioids from the surgical-related pain. Not preventing PONV will cause nausea and vomiting to at least 60 to 80 percent of patients who exhibit at minimum three of the known risk factors. The current treatment options that prevent post-surgery nausea and vomiting include classes of corticosteroid and serotonin 5-HT3; which are given intraoperatively. However, this was never enough and an additional drug needed to be developed and administered in combination with previous treatments to maximize efficacy; "safe and effective anti-nausea drugs from other classes are needed to complement these," says Dr. Kranke, a lead researcher of the study.

Furthermore, the mechanism of Amisulpride works physiologically to inhibit dopamine signaling in the body. Comparable dopamine-blocking compounds were examined to prevent and treat post-surgical nausea and vomiting; however, these treatments are now disregarded due to associated side effects involving irregular heartbeats and movement disorders. Therefore, Amisulpride is safe and effective in comparison to the other known drug treatments.

The research study, published in the journal Anesthesiology, examined 1,147 adult patients that were administered general anesthesia and undergoing elective surgery, and who also possess at least three or four of the PONV risk factors. The patients were randomly matched to a type of amisulpride administration and with an additional anti-nausea drug treatment with a placebo. Investigators concluded that high-risk surgical patients receiving a low dose of intravenous Amisulpride in combination an anti-nausea drug (from a different class of compounds) were safe and effective. "This could enable improved control of PONV and allow for earlier mobilization and discharge of surgical patients," Dr. Kranke said.

As of now, the U.S. Food and Drug Administration is reviewing the use of Amisulpride.

Sources: Anesthesiology, Medical Xpress

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 13, 2020
Cancer
APR 13, 2020
The Unexpected Role of Mono in Cancer Progression
In the past, the go-to drugs have always been small molecules. These small molecules would interact with the cell and ac ...
APR 15, 2020
Immunology
APR 15, 2020
Why More Men than Women Die from COVID-19
As of April 9th, over 60% of deaths from COVID-19 in New York state were men. Meanwhile, as of April 6, 82% of patients ...
APR 22, 2020
Drug Discovery & Development
APR 22, 2020
Only 3% of COVID-19 Antibody Tests Approved by FDA
So far, only 3% of at least 90 COVID-19 antibody tests in the US have been approved by the Food and Drug Administration ...
APR 23, 2020
Drug Discovery & Development
APR 23, 2020
Over 200 Volunteers Design $216 Ventilator for COVID-19
Over 200 volunteers from France have designed a ventilator suitable to treat COVID-19 patients that costs less than $500 ...
APR 27, 2020
Drug Discovery & Development
APR 27, 2020
Making Cardiac Medicine From Foxglove Plants
Foxglove plants are known to be shaped like bells and have long decorated many gardens. They belong to a genus of plants ...
MAY 21, 2020
Cancer
MAY 21, 2020
A New Player in the Regulation of Cancer's Microenvironment
Breast cancer is one of the most common cancers in the world.  Triple-negative breast cancer (TNBC) is a sub-type o ...
Loading Comments...